학술논문
Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial
Document Type
Article
Author
Penault-Llorca, F.; Dalenc, F.; Chabaud, S.; Cottu, P.; Allouache, D.; Cameron, D.; Grenier, J.; Venat Bouvet, L.; Jegannathen, A.; Campone, M.; Debled, M.; Hardy-Bessard, A.-C.; Giacchetti, S.; Barthelemy, P.; Kaluzinski, L.; Mailliez, A.; Mouret-Reynier, M.-A.; Legouffe, E.; Cayre, A.; Martinez, M.; Delbaldo, C.; Mollon-Grange, D.; Macaskill, E.J.; Sephton, M.; Stefani, L.; Belgadi, B.; Winter, M.; Orfeuvre, H.; Lacroix-Triki, M.; Bonnefoi, H.; Bliss, J.; Canon, J.-L.; Lemonnier, J.; Andre, F.; Bachelot, T.
Source
In ESMO Open May 2024 9(5)
Subject
Language
ISSN
2059-7029